- Home
- REE vs PSTV Comparison
REE vs PSTV Comparison
Compare REE & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- PSTV
- Stock Information
- Founded
- REE 2011
- PSTV 1996
- Country
- REE Israel
- PSTV United States
- Employees
- REE N/A
- PSTV N/A
- Industry
- REE Auto Manufacturing
- PSTV Medical/Dental Instruments
- Sector
- REE Consumer Discretionary
- PSTV Health Care
- Exchange
- REE Nasdaq
- PSTV Nasdaq
- Market Cap
- REE 18.5M
- PSTV 17.0M
- IPO Year
- REE N/A
- PSTV N/A
- Fundamental
- Price
- REE $0.76
- PSTV $0.53
- Analyst Decision
- REE Strong Buy
- PSTV Strong Buy
- Analyst Count
- REE 2
- PSTV 3
- Target Price
- REE $11.75
- PSTV $10.83
- AVG Volume (30 Days)
- REE 129.4K
- PSTV 19.1M
- Earning Date
- REE 09-25-2025
- PSTV 08-13-2025
- Dividend Yield
- REE N/A
- PSTV N/A
- EPS Growth
- REE N/A
- PSTV N/A
- EPS
- REE N/A
- PSTV N/A
- Revenue
- REE $183,000.00
- PSTV $5,206,000.00
- Revenue This Year
- REE $6,661.20
- PSTV $14.10
- Revenue Next Year
- REE $2,240.01
- PSTV $7.96
- P/E Ratio
- REE N/A
- PSTV N/A
- Revenue Growth
- REE N/A
- PSTV N/A
- 52 Week Low
- REE $0.53
- PSTV $0.16
- 52 Week High
- REE $11.72
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- REE 49.95
- PSTV 64.56
- Support Level
- REE $0.67
- PSTV $0.27
- Resistance Level
- REE $0.80
- PSTV $0.71
- Average True Range (ATR)
- REE 0.05
- PSTV 0.05
- MACD
- REE 0.04
- PSTV 0.03
- Stochastic Oscillator
- REE 77.06
- PSTV 53.79
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).